Of course! Tecvayli (teclistamab-cqyv) is a treatment used for relapsed or refractory multiple myeloma. What would you like to know about it? Feel free to ask anything — whether it's about how it works, side effects, eligibility, or something else entirely.
In the meantime, here's a quick overview:
- What it is: A Show Full Answer
Of course! Tecvayli (teclistamab-cqyv) is a treatment used for relapsed or refractory multiple myeloma. What would you like to know about it? Feel free to ask anything — whether it's about how it works, side effects, eligibility, or something else entirely.
In the meantime, here's a quick overview:
- What it is: A bispecific T-cell engager (BiTE) — a type of immunotherapy
- How it works: It targets two proteins at once — BCMA on myeloma cells and CD3 on T cells — bringing them together so the T cells can destroy the myeloma cells
- How it's given: As an injection under the skin (subcutaneous)
- Who it's approved for: Adults with relapsed or refractory myeloma who have had at least one prior line of therapy including a proteasome inhibitor and an immunomodulatory agent
There's also a newly FDA-approved combination of Tecvayli plus Darzalex Faspro, which showed an 83% reduction in the risk of disease progression compared to standard treatments.
Just ask away with your specific question!
April 25
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
